Skip to main content
Fig. 1 | BMC Research Notes

Fig. 1

From: Expression of the miR-200 family in tumor tissue, plasma and urine of epithelial ovarian cancer patients in comparison to benign counterparts

Fig. 1

Expression of miR-200a, miR-200b and miR-200c in clinical samples. Relative expression levels of miR-200a, miR-200b and miR-200c in plasma, urine and tumor tissue of the HGSOC patients and patients with benign ovarian tumors (the graphs show mean and SD). HGSOC patients marked with asterisk (*) had no extensive peritoneal carcinosis in addition to ovarian tumors as did rest of the cancer patients. Except patient 30 they had lower stage of the disease (IIIA or IIIB) compared to rest of the HGSOC patients (IIIC or IVB). Patient 30 had liver metastasis of 6 cm, which raised the stage into IVB. The expression levels in tissue samples are normalized against RNU6B. The expression levels in plasma and urine samples are normalized against spiked-in cel-miR-39. The liquid samples from patient 63 were not available

Back to article page